LEO Pharma RD

LEO Pharma

Innovative Pharmaceuticals

LEO Pharma is a leader in medical dermatology with a robust R&D pipeline across a wide range of therapies enabling people with severe skin diseases to access medicine and treatment.

Company Background

  • Advancing the science of dermatology with a leading branded topical dermatology franchise based on decades of research and development
  • Setting new standards of care for people with skin conditions with a global team of 6,000 people, serving 93 million patients in more than 130 countries

Vision & Outlook

Support LEO Pharma on its journey to strengthening its global leadership in medical dermatology

Help to expand the company's dermatology franchise and to accelerate innovation and growth

Highlights & Updates

  • Committed to net zero climate target aligned with SBTi and launched ESG linked financing
LEO Pharma Logo

SECTOR

Healthcare

REVENUES 2021

EUR 1,370 million

EMPLOYEES

5,620

OWNERSHIP

Fund X

HEAD OFFICE

Denmark

INVESTMENT DATE

2021

MANAGEMENT

Christophe Bourdon

CEO

Philip Eickhoff

CFO

CHAIRPERSON

Jesper Brandgaard

Chair

RESPONISBLE ADVISORS

Raj Shah

Partner | Head of Healthcare

Jonas Agnblad

Partner | Co-Head of Healthcare